Edition:
United States

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

27,145.73ZAc
28 Mar 2017
Change (% chg)

145.73 (+0.54%)
Prev Close
27,000.00
Open
26,980.00
Day's High
27,369.00
Day's Low
26,610.00
Volume
1,026,745
Avg. Vol
1,292,291
52-wk High
38,849.00
52-wk Low
26,266.00

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited supplies and manufactures branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries... (more)

Overall

Beta: 0.84
Market Cap(Mil.): R123,237.50
Shares Outstanding(Mil.): 456.44
Dividend: 248.00
Yield (%): 0.92

Financials

  APNJ.J Industry Sector
P/E (TTM): 32.58 29.24 29.98
EPS (TTM): 8.29 -- --
ROI: 5.07 13.55 13.08
ROE: 9.14 14.45 14.23

UPDATE 1-South Africa's Aspen Pharmacare sees growth in China sales

JOHANNESBURG, March 9 South Africa's Aspen Pharmacare forecasts sales of about 2 billion rand ($152 million) in China over the next 12 months, the drugmaker's chief executive said on Thursday after reporting a 6 percent rise in first-half profit.

Mar 09 2017

South Africa's Aspen expects China to deliver $150 mln in sales in next 12 months -CEO

JOHANNESBURG, March 9 South Africa's Aspen Pharmacare forecasts sales of about 2 billion rand ($152 million)in China over the next 12 months, the drugmaker's chief executive said on Thursday.

Mar 09 2017

South Africa's Aspen posts 6 pct rise in H1 profit

JOHANNESBURG, March 9 South African drugmaker Aspen Pharmacare Holdings Ltd reported a 6 percent rise in first-half profit on Thursday, helped by the results of a recently acquired portfolio of medicines from AstraZeneca .

Mar 09 2017

BRIEF-Aspen Pharmacare sees HEPS for six months to Dec.31 up 49-57 pct

* Sees six months to dec.31 headline earnings per share up 49 pct to 57 pct , between 624.0 to 657.5 cents

Mar 01 2017

BRIEF-Aspen completes acquisition of a portfolio of anaesthetics with GlaxoSmithKline

* Aspen Holdings is pleased to announce that this transaction completed Source text for Eikon: Further company coverage:

Mar 01 2017

BRIEF-GSK gets 477 mln stg gross proceeds from Aspen Pharmacare stake sale

* Gross proceeds of Aspen transaction are equivalent to £477 million Source text for Eikon: Further company coverage: (Reporting by UK bureau)

Sep 29 2016

More From Around the Web

Earnings vs. Estimates